FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers

Cell Research

Volumn 21, Issue 2, 2011, Pages 316-326

  Tang, Yunneng ^a   Shu, Guangwen ^a   Yuan, Xinwang ^a   Jing, Naihe ^a   Song, Jianguo ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

EMT; FOXA2; lung tumors; slug; TGF 1

Indexed keywords

FOXA2 PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3BETA; SMALL INTERFERING RNA; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PROMOTER REGION; PROTEIN BINDING; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA;

EID: 79651473733     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.126     Document Type: Article

References (38)

1. Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transi-tion and cell cooperativity in metastasis. Cancer Res 2009; 69:7135-7139.
2. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mes-enchymal transitions in development and disease. Cell 2009; 139:871-890.
3. Cannito S, Novo E, Di Bonzo LV, Busletta C, Colombatto S, Parola M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal 2010; 12:1383-1430
4. Thiery JP, Sleeman JP. Complex networks orchestrate epithe-lial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-142. (Pubitemid 43278296)
5. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-558. (Pubitemid 41267170)
6. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009; 21:166-176.
7. Yang Y, Pan X, Lei W, Wang J, Song J. Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 2006; 25:7235-7244. (Pubitemid 44809089)
8. Katoh M. Human FOX gene family (Review). Int J Oncol 2004; 25:1495-1500.
9. Kaestner KH, Lee KH, Schlondorff J, Hiemisch H, Monaghan AP, Schutz G. Six members of the mouse forkhead gene fam-ily are developmentally regulated. Proc Natl Acad Sci USA 1993; 90:7628-7631. (Pubitemid 23250003)
10. Friedman JR, Kaestner KH. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 2006; 63:2317-2328. (Pubitemid 44653042)
11. Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, Kaestner KH. Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat Med 2008; 14:828-836.
12. Wolfrum C, Stoffel M. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab 2006; 3:99-110.
13. Puigserver P, Rodgers JT. Foxa2, a novel transcriptional regu-lator of insulin sensitivity. Nat Med 2006; 12:38-39. (Pubitemid 43050058)
14. Khoor A, Stahlman MT, Johnson JM, Olson SJ, Whitsett JA. Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors. Hum Pathol 2004; 35:560-564. (Pubitemid 38656939)
15. Lehner F, Kulik U, Klempnauer J, Borlak J. The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases. FASEB J 2007; 21:1445-1462. (Pubitemid 46684847)
16. Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 2005; 6:56.
17. Shi J, Wang DM, Wang CM, et al. Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithe-lial-mesenchymal transition. Cancer Res 2009; 69:7180-7187.
18. Thisse C, Thisse B, Postlethwait JH. Expression of snail2, a second member of the zebrafish snail family, in cephalic mesendoderm and presumptive neural crest of wild-type and spadetail mutant embryos. Dev Biol 1995; 172:86-99.
19. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-fnger pro-tein represses E-cadherin in breast cancer. Cancer Res 2002; 62:1613-1618. (Pubitemid 34408479)
20. Savagner P, Yamada KM, Thiery JP. The zinc-fnger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transi-tion. J Cell Biol 1997; 137:1403-1419. (Pubitemid 27265951)
21. Medici D, Hay ED, Olsen BR. Snail and slug promote epithe-lial- mesenchymal transition through beta-catenin-t-cell factor-4-dependent expression of transforming growth factor-beta 3. Mol Biol Cell 2008; 19:4875-4887.
22. Shioiri M, Shida T, Koda K, et al. Slug expression is an inde-pendent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer 2006; 94:1816-1822. (Pubitemid 43882571)
23. Qian X, Costa RH. Analysis of hepatocyte nuclear factor-3 beta protein domains required for transcriptional activation and nuclear targeting. Nucleic Acids Res 1995; 23:1184-1191.
24. Overdier DG, Porcella A, Costa RH. The DNA-binding speci-fcity of the hepatocyte nuclear factor 3/forkhead domain is infuenced by amino-acid-residues adjacent to the recognition helix. Mol Cell Biol 1994; 14:2755-2766. (Pubitemid 24108256)
25. Pani L, Overdier DG, Porcella A, Qian X, Lai E, Costa RH. Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein. Mol Cell Biol 1992; 12:3723-3732.
26. Qian XB, Costa RH. Analysis of hepatocyte nuclear factor-3-beta protein domains required for transcriptional activation and nuclear targeting. Nucleic Acids Res 1995; 23:1184-1191.
27. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2:533-543. (Pubitemid 33586866)
28. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide allelotyping of lung cancer identifes new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci cluster-ing. Cancer Res 2000; 60:4894-4906.
29. Sekiya T, Muthurajan UM, Luger K, Tulin AV, Zaret KS. Nucleosome-binding affnity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes Dev 2009; 23:804-809.
30. Morita T, Mayanagi T, Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transi-tion via slug induction and actin remodeling. J Cell Biol 2007; 179:1027-1042. (Pubitemid 350223496)
31. Wan H, Xu Y, Ikegami M, et al. Foxa2 is required for transi-tion to air breathing at birth. Proc Natl Acad Sci USA 2004; 101:14449-14454. (Pubitemid 39346769)
32. Burtscher I, Lickert H. Foxa2 regulates polarity and epithe-lialization in the endoderm germ layer of the mouse embryo. Development 2009; 136:1029-1038.
33. Song Y Washington MK, Crawford HC. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pan-creatic cancer. Cancer Res 2010; 70:2115-2125.
34. Zhang KH, Tian HY, Gao X, et al. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesen-chymal transition. Cancer Res 2009; 69:5340-5348.
35. Chen HH, Zhao S, Song JG. TGF-beta1 suppresses apoptosis via differential regulation of MAP kinases and ceramide pro-duction. Cell Death Differ 2003; 10:516-527. (Pubitemid 36656641)
36. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452:187-193. (Pubitemid 351380252)
37. Padua D, Zhang XH, Wang Q, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008; 133:66-77. (Pubitemid 351442989)
38. Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98:1512-1520.